case_images: PMC5701586_01
case_images: Pretreatment CT shows one target lesion measuring 87 mm in diameter and attenuation of 81 HU (arrow)
case_images: WO-21-30596-g001.jpg
case_images: PMC5701586_01_WO-21-30596-g001.jpg
case_images: f0001
case_images: Subsequently, based on CT scans, as well as a clinical evaluation the patient was qualified for transarterial chemoembolization (Fig. 1, 2).
case_images: CT scan after the last cycle of TACE showing decrease in diameter of the target lesion (60 mm) and a decrease in attenuation - 39 HU (arrow)
case_images: WO-21-30596-g002.jpg
case_images: PMC5701586_01_WO-21-30596-g002.jpg
case_images: f0002
case_images: Subsequently, based on CT scans, as well as a clinical evaluation the patient was qualified for transarterial chemoembolization (Fig. 1, 2).
case_images: Pretreatment angiogram shows diffuse pattern of contrast enhancement throughout liver without distinct nodules
case_images: WO-21-30596-g003.jpg
case_images: PMC5701586_01_WO-21-30596-g003.jpg
case_images: f0003
case_images: The angiographic image of metastases was diffuse infliltrative staining pattern without distinct nodularity (Fig. 3).